![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Z Mi and EK Jackson
Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pennsylvania, USA.
Although adenosine contributes importantly to the regulation of renin release, renal vascular resistance and renal tubular reabsorption, the metabolic pathways that control the intrarenal production rate of adenosine remain ill defined. The objective of this study was to determine whether extracellular metabolism of cyclic AMP to AMP by extracellular phosphodiesterase and hence to adenosine by ecto-5'- nucleotidase can occur in the intact kidney. To test this hypothesis, five experimental series were conducted in kidneys from male Sprague- Dawley rats perfused in a nonrecirculating system (5 ml/min) in vitro with oxygenated Tyrode's solution at 37 degrees C. In each experimental series, cyclic AMP was added to the Tyrode's solution and the renal secretion rates (i.e., the renal venous concentration of purine x the perfusion flow rate) of AMP, adenosine and inosine were determined using high-performance liquid chromatography. In the first experimental series, only cyclic AMP was added to the perfusate. In the second, third, fourth and fifth experimental series, kidneys were perfused with Tyrode's solution containing both cyclic AMP and either 3-isobutyl-1- methylxanthine (a phosphodiesterase inhibitor), alpha,beta- methyleneadenosine-5'-diphosphate (an ecto-5'-nucleotidase inhibitor), dilazep (an adenosine transport inhibitor) or 1,3-dipropyl-8-p- sulfophenylxanthine (a xanthine that is restricted to the extracellular compartment). In the first experimental series (n = 8), addition of cyclic AMP to the perfusate resulted in significant concentration- related increases in the renal secretion rates of AMP, adenosine and inosine, with the increase in AMP secretion being significantly greater than the increases in adenosine or inosine secretions (delta adenosine secretion/delta AMP secretion = 0.38 +/- 0.10).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  E. L. Liclican, J. C. McGiff, J. R. Falck, and M. A. Carroll Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1696 - F1704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ren, Z. Mi, and E. K. Jackson Assessment of Nerve Stimulation-Induced Release of Purines from Mouse Kidneys by Tandem Mass Spectrometry J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 920 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson and Z. Mi Regulation of Renal Ectophosphodiesterase by Protein Kinase C and Sodium Diet J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 210 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson, J. Ren, L. C. Zacharia, and Z. Mi Characterization of Renal Ecto-Phosphodiesterase J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 810 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson, Z. Mi, and R. K. Dubey The Extracellular cAMP-Adenosine Pathway Significantly Contributes to the in Vivo Production of Adenosine J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 117 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson, L. C. Zacharia, M. Zhang, D. G. Gillespie, C. Zhu, and R. K. Dubey cAMP-Adenosine Pathway in the Proximal Tubule J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1219 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. Carey, L. J. Wotjukiewicz, J. M. Goodman, K. E. Reineck, and K. C. Overman Extracellular Cyclic AMP and Adenosine Appearance in Adipose Tissue of Sus scrofa: Effects of Exercise Experimental Biology and Medicine, November 1, 2004; 229(10): 1026 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson, Z. Mi, C. Zhu, and R. K. Dubey Adenosine Biosynthesis in the Collecting Duct J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 888 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Cometti, R. K. Dubey, B. Imthurn, E. K. Jackson, and M. Rosselli Oviduct Cells Express the Cyclic AMP-Adenosine Pathway Biol Reprod, September 1, 2003; 69(3): 868 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Zacharia, R. K. Dubey, Z. Mi, and E. K. Jackson Methylation of 2-Hydroxyestradiol in Isolated Organs Hypertension, July 1, 2003; 42(1): 82 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bankir, M. Ahloulay, P. N. Devreotes, and C. A. Parent Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved? Am J Physiol Renal Physiol, March 1, 2002; 282(3): F376 - F392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Endogenous Cyclic AMP-Adenosine Pathway Regulates Cardiac Fibroblast Growth Hypertension, April 1, 2001; 37(4): 1095 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Dubey, Z. Mi, D. G. Gillespie, and E. K. Jackson Dysregulation of Extracellular Adenosine Levels by Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Jackson and Z. Mi Preglomerular Microcirculation Expresses the cAMP-Adenosine Pathway J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 23 - 28. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Cardiac Fibroblasts Express the cAMP-Adenosine Pathway Hypertension, September 1, 2000; 36(3): 337 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Andresen, D. G. Gillespie, Z. Mi, R. K. Dubey, and E. K. Jackson Role of Adenosine A1 Receptors in Modulating Extracellular Adenosine Levels J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 76 - 80. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Di Sole, V. Casavola, L. Mastroberardino, F. Verrey, O. W Moe, G. Burckhardt, H. Murer, and C. Helmle-Kolb Adenosine inhibits the transfected Na+-H+ exchanger NHE3 in Xenopus laevis renal epithelial cells (A6/C1) J. Physiol., March 15, 1999; 515(3): 829 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Hong, H. K. Shin, H. H. Kim, J. M. Choi, B. Y. Rhim, and W. S. Lee Metabolism of cAMP to adenosine: role in vasodilation of rat pial artery in response to hypotension Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H376 - H382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mi and E. K. Jackson Effects of alpha - and beta -Adrenoceptor Blockade on Purine Secretion Induced by Sympathetic Nerve Stimulation in the Rat Kidney J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 295 - 301. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Mi and E. K. Jackson Evidence for an Endogenous cAMP-Adenosine Pathway in the Rat Kidney J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 926 - 930. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Exogenous and Endogenous Adenosine Inhibits Fetal Calf Serum–Induced Growth of Rat Cardiac Fibroblasts : Role of A2B Receptors Circulation, October 21, 1997; 96(8): 2656 - 2666. [Abstract] [Full Text]
|
|
|
|
|
|
E. K. Jackson, Z. Mi, D. G. Gillespie, and R. K. Dubey Metabolism of cAMP to Adenosine in the Renal Vasculature J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 177 - 182. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Dubey, Z. Mi, D. G. Gillespie, and E. K. Jackson Cyclic AMP–Adenosine Pathway Inhibits Vascular Smooth Muscle Cell Growth Hypertension, November 1, 1996; 28(5): 765 - 771. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Dubey, D. G. Gillespie, Z. Mi, F. Suzuki, and E. K. Jackson Smooth Muscle Cell–Derived Adenosine Inhibits Cell Growth Hypertension, March 1, 1996; 27(3): 766 - 773. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Dubey, D. G. Gillespie, K. Osaka, F. Suzuki, and E. K. Jackson Adenosine Inhibits Growth of Rat Aortic Smooth Muscle Cells : Possible Role of A2b Receptor Hypertension, March 1, 1996; 27(3): 786 - 793. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
